Validation of minimal risk of recurrence classification by the Breast Cancer Index in early stage breast cancer

Abstract The Breast Cancer Index (BCI) was previously shown to identify ~20% of postmenopausal patients with early stage, hormone receptor positive (HR+), node negative (N0) breast cancer with minimal (<5%) risk of 10-year distant recurrence (DR) even without receiving adjuvant endocrine therapy (ET...

Descripció completa

Dades bibliogràfiques

Autors principals:	Marie-France Jilderda, John M. S. Bartlett, Gerrit-Jan Liefers, Yi Zhang, Hywel Dunn-Davies, Valerie Rebattu, Ranelle Salunga, Elma Meershoek-Klein Kranenbarg, Linda de Munck, Annette Hasenburg, Christos Markopoulos, Luc Dirix, Cornelis J. H. van de Velde, Daniel Rea, Amanda K. L. Anderson, Esther Bastiaannet, Kai Treuner, Karen J. Taylor
Format:	Artigo
Idioma:	Inglês
Publicat:	Nature Portfolio 2025-12-01
Col·lecció:	npj Breast Cancer
Accés en línia:	https://doi.org/10.1038/s41523-025-00885-x
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!